These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1386954)

  • 1. Cellular response and anti-HBs synthesis in vitro after vaccination with yeast-derived recombinant hepatitis vaccine.
    Degrassi A; Mariani E; Honorati MC; Roda P; Miniero R; Capelli M; Facchini A
    Vaccine; 1992; 10(9):617-22. PubMed ID: 1386954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation between in vivo humoral and in vitro cellular immune responses following immunization with hepatitis B surface antigen (HBsAg) vaccines.
    Leroux-Roels G; Van Hecke E; Michielsen W; Voet P; Hauser P; Pêtre J
    Vaccine; 1994 Jul; 12(9):812-8. PubMed ID: 7975860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Humoral and cellular immune responses to hepatitis B vaccination in hepatitis B surface antigen-carrier children who cleared serum-hepatitis B surface antigen.
    Hsu HY; Chang MH; Hsieh RP; Ni YH; Chi WK
    Hepatology; 1996 Dec; 24(6):1355-60. PubMed ID: 8938161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody responses to recombinant, yeast-derived hepatitis B vaccine in teenage New Zealand children.
    Milne A; Moyes CD; Allwood GK; Pearce NE; Krugman S
    N Z Med J; 1988 Feb; 101(840):67-9. PubMed ID: 2967940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistence of antibodies after immunization with a recombinant yeast-derived hepatitis B vaccine following two different schedules.
    Scheiermann N; Gesemann M; Maurer C; Just M; Berger R
    Vaccine; 1990 Mar; 8 Suppl():S44-6; discussion S60-2. PubMed ID: 2139282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro anti-HBs antibody synthesis from anti-hepatitis B vaccine recipients.
    Barnaba V; Levrero M; Ruberti G; van Dyke A; Perrone A; Musca A; Balsano F
    Clin Exp Immunol; 1987 Nov; 70(2):283-8. PubMed ID: 2962789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis B virus (HBV)-specific in vitro antibody production by peripheral blood mononuclear cells (PBMC) after vaccination by recombinant hepatitis B surface antigen (rHBsAg).
    Ducos J; Bianchi-Mondain AM; Pageaux G; Conge AM; Poncet R; Vendrell JP; Segondy M; Serre A
    Clin Exp Immunol; 1996 Jan; 103(1):15-8. PubMed ID: 8565275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenicity of yeast-derived hepatitis B vaccine from two different producers.
    Dahl-Hansen E; Siebke JC; Frøland SS; Degré M
    Epidemiol Infect; 1990 Feb; 104(1):143-9. PubMed ID: 2137785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of immunogenicity of two yeast-derived recombinant hepatitis B vaccines.
    Hammond GW; Parker J; Mimms L; Tate R; Sekla L; Minuk G
    Vaccine; 1991 Feb; 9(2):97-100. PubMed ID: 1829306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the immune response of four different dosages of a yeast-recombinant hepatitis B vaccine in Singapore children: a four-year follow-up study.
    Goh KT; Tan KL; Kong KH; Oon CJ; Chan SH
    Bull World Health Organ; 1992; 70(2):233-9. PubMed ID: 1600584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity and safety in newborns of a new recombinant hepatitis B vaccine containing the S and pre-S2 antigens.
    Soulié JC; Devillier P; Santarelli J; Goudeau A; Vermeulen P; Guellier M; Saliou P; Hillion AM; Tron F; Huchet J
    Vaccine; 1991 Aug; 9(8):545-8. PubMed ID: 1837646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistence of antibodies following vaccination with a yeast-derived recombinant hepatitis B vaccine.
    Just M; Berger R; Scheiermann N
    Vaccine; 1988 Oct; 6(5):401-2. PubMed ID: 2973694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody response after intradermal administration of recombinant hepatitis B vaccine in children.
    Wiström J; Gustafsson A
    Scand J Infect Dis; 1990; 22(5):621-2. PubMed ID: 2148015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the immunogenicity of reduced doses of two recombinant DNA hepatitis B vaccines in New Zealand children.
    Milne A; Brawner TA; Dumbill PC; Kawachi I; Pearce NE
    J Med Virol; 1989 Mar; 27(3):264-7. PubMed ID: 2524549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prospective study of in vitro anti-HBs producing B cells (spot-ELISA) following primary and supplementary vaccination with a recombinant hepatitis B vaccine in insulin dependent diabetic patients and matched controls.
    Wismans PJ; van Hattum J; de Gast GC; Bouter KP; Diepersloot RJ; Maikoe T; Mudde GC
    J Med Virol; 1991 Nov; 35(3):216-22. PubMed ID: 1839554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of different dose levels and vaccination schedules on immune response to a recombinant DNA hepatitis B vaccine in haemodialysis patients.
    Bruguera M; Rodicio JL; Alcazar JM; Oliver A; Del Rio G; Esteban-Mur R
    Vaccine; 1990 Mar; 8 Suppl():S47-9; discussion S60-2. PubMed ID: 2139283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune response to hepatitis B vaccine in premature neonates.
    Chawareewong S; Jirapongsa A; Lokaphadhana K
    Southeast Asian J Trop Med Public Health; 1991 Mar; 22(1):39-40. PubMed ID: 1835140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved immunogenicity in mice of a mammalian cell-derived recombinant hepatitis B vaccine containing pre-S1 and pre-S2 antigens as compared with conventional yeast-derived vaccines.
    Shouval D; Ilan Y; Adler R; Deepen R; Panet A; Even-Chen Z; Gorecki M; Gerlich WH
    Vaccine; 1994 Nov; 12(15):1453-9. PubMed ID: 7533967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunogenicity and harmlessness in the newborn of a vaccine (GenHevac B) containing the antigens S and pre-S2].
    Tron F; Soulié JC; Goudeau A; Devillier P; Saliou P
    Bull Soc Pathol Exot; 1991; 84(5 Pt 5):901-5. PubMed ID: 1840243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The safety and immunogenicity of a recombinant hepatitis B vaccine in neonates.
    Gunn TR; Bosley A; Woodfield DG
    N Z Med J; 1989 Jan; 102(860):1-3. PubMed ID: 2521527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.